Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H FLEISCH

Showing results (201-210 of 212) with videos related to

Pageof 22
Sort By:
Agents and Actions|June 1, 1989
Leukotriene (LT) receptor antagonists. Heterocycle-linked tetrazoles and carboxylic acids. LY203647W S Marshall, S K Sigmund, C A Whitesitt, et al.
Journal of Medicinal Chemistry|April 3, 1992
Development of a series of phenyltetrazole leukotriene D4 (LTD4) receptor antagonistsR W Harper, D K Herron, N G Bollinger, et al.
Development (Cambridge, England)|June 1, 1994
Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouseM G Cecchini, M G Dominguez, S Mocci, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1990
Leukotriene receptor antagonism and augmentation of beta-receptor-mediated events by LY171883L E Rinkema, C R Roman, W L Russell, et al.
European Journal of Pharmacology|November 23, 1992
Pulmonary actions of LY255283, a leukotriene B4 receptor antagonistS A Silbaugh, P W Stengel, S L Cockerham, et al.
Journal of Medicinal Chemistry|October 27, 1995
Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonistJ S Sawyer, N J Bach, S R Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Current use of bisphosphonates in oncology. International Bone and Cancer Study GroupJ J Body, R Bartl, P Burckhardt, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitorJ H Fleisch, C T Armstrong, C R Roman, et al.
Brain Research|July 19, 2000
ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemiaM J O'Neill, T K Murray, D R McCarty, et al.
Brain Research|January 9, 2001
LY393615, a novel neuronal Ca(2+) and Na(+) channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemiaM J O'Neill, C A Hicks, M A Ward, et al.
Pageof 22

Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Agents and Actions|June 1, 1989
Leukotriene (LT) receptor antagonists. Heterocycle-linked tetrazoles and carboxylic acids. LY203647W S Marshall, S K Sigmund, C A Whitesitt, et al.
Journal of Medicinal Chemistry|April 3, 1992
Development of a series of phenyltetrazole leukotriene D4 (LTD4) receptor antagonistsR W Harper, D K Herron, N G Bollinger, et al.
Development (Cambridge, England)|June 1, 1994
Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouseM G Cecchini, M G Dominguez, S Mocci, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1990
Leukotriene receptor antagonism and augmentation of beta-receptor-mediated events by LY171883L E Rinkema, C R Roman, W L Russell, et al.
European Journal of Pharmacology|November 23, 1992
Pulmonary actions of LY255283, a leukotriene B4 receptor antagonistS A Silbaugh, P W Stengel, S L Cockerham, et al.
Journal of Medicinal Chemistry|October 27, 1995
Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonistJ S Sawyer, N J Bach, S R Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Current use of bisphosphonates in oncology. International Bone and Cancer Study GroupJ J Body, R Bartl, P Burckhardt, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitorJ H Fleisch, C T Armstrong, C R Roman, et al.
Brain Research|July 19, 2000
ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemiaM J O'Neill, T K Murray, D R McCarty, et al.
Brain Research|January 9, 2001
LY393615, a novel neuronal Ca(2+) and Na(+) channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemiaM J O'Neill, C A Hicks, M A Ward, et al.
Pageof 22